US · BMGL
Basel Medical Group Ltd Ordinary Shares
- Sector
- Healthcare · Medical - Healthcare Plans
- Headquarters
- Singapore 188778
- Website
- baselmedical.com
Price · as of 2025-06-30
$0.56
Market cap 11.28M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $2,253.90 | +402,382.14% |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $2.02 | $2,909.76 |
AI valuation
Our deep-learning model estimates Basel Medical Group Ltd Ordinary Shares's (BMGL) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $2,253.90
- Current price
- $0.56
- AI upside
- +402,382.14%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| BMGL | Basel Medical Group Ltd O… | $0.56 | 11.28M | +519,500% | — | — | — | — | — | — | — | — | — | 77.68% | -19.28% | -106.78% | -201.33% | -27.76% | -75.42% | 0.70 | -10.70 | 1.23 | 0.51 | -0.04 | -10000.00% | 1263.00% | -27586.00% | — | -0.41 | -57.87% | — | 0.00% | — | — | — | — | — |
| IBIO | iBio, Inc. | $2.82 | 44.53M | +1,048% | -88% | — | — | -0.48 | 0.59 | 22.05 | -0.22 | — | 1.10 | 100.00% | -4650.50% | -4594.25% | -101.52% | -174.01% | -70.79% | 0.24 | -87.75 | 1.59 | 1.42 | 0.30 | -7308.00% | 7778.00% | -1835.00% | -173.71% | -2.51 | -143.31% | 0.00% | 0.00% | 0.00% | -0.20 | -0.24 | 9.36 | -21.87 |
| INTS | Intensity Therapeutics, I… | $7.66 | 14.45M | — | — | — | — | -1.89 | 10.53 | — | -1.74 | — | 10.53 | 0.00% | — | — | -202.34% | 3350.51% | -147.37% | 0.05 | — | 1.92 | 1.48 | 0.15 | -1522.00% | — | 11124.00% | -49.52% | -8.67 | 3074.75% | 0.00% | 0.00% | 0.00% | -1.71 | -1.86 | — | -20.70 |
| ITRM | Iterum Therapeutics plc | $0.26 | 13.97M | — | — | — | — | -1.10 | -6.66 | — | -2.24 | — | -1.14 | 0.00% | — | — | 472.61% | -628.33% | -69.93% | -11.16 | — | 1.41 | 1.37 | -0.99 | -5743.00% | — | -3195.00% | -98.48% | -1.52 | -899.75% | 0.00% | 0.00% | 0.00% | -2.60 | -1.82 | — | -16.11 |
| MODD | Modular Medical, Inc. | $0.25 | 15.64M | — | — | — | — | -1.66 | 1.83 | — | -1.09 | — | 1.83 | 0.00% | — | — | -131.58% | -459.49% | -115.69% | 0.05 | — | 10.69 | 10.41 | 0.71 | -3462.00% | — | 1636.00% | -58.31% | -12.43 | -439.34% | 0.00% | 0.00% | 13.57% | -1.00 | -1.04 | — | 2.40 |
| NTRB | Nutriband Inc. | $4.44 | 54.06M | +340% | -57% | — | — | -4.78 | 7.79 | 23.39 | -4.51 | -10.98 | 11.26 | 32.68% | -312.62% | -489.86% | -162.94% | -157.60% | -139.89% | 0.03 | -312.51 | 4.88 | 4.46 | 0.41 | 4348.00% | 262.00% | 3184.00% | -9.43% | -4.71 | -111.17% | 0.00% | 0.00% | 8.03% | -6.87 | -9.73 | 21.47 | 19.59 |
| PIII | P3 Health Partners Inc. | $2.12 | 6.93M | +1,116% | +75% | — | — | -0.09 | 0.35 | 0.02 | -0.78 | -0.11 | -0.05 | 100.00% | -21.37% | -9.05% | -284.66% | -147.86% | -37.75% | 2.19 | -14.46 | 0.37 | 0.33 | -0.64 | 7758.00% | 1848.00% | 4145.00% | -409.98% | -0.22 | -50.78% | 0.00% | 0.00% | 0.00% | -0.48 | -1.40 | 0.10 | -0.79 |
| PRPO | Precipio, Inc. | $24.08 | 42.19M | +4,189% | +1,762% | — | — | -2.37 | 0.84 | 0.64 | -3.70 | — | 45.11 | 47.35% | -26.41% | -26.87% | -32.35% | -32.43% | -24.45% | 0.10 | -56.97 | 0.81 | 0.51 | 0.05 | -3503.00% | 505.00% | -10586.00% | 2.13% | 0.10 | 1.66% | 0.00% | 0.00% | 0.00% | -2.37 | 46.36 | 0.63 | -7.13 |
| RBOT | Vicarious Surgical Inc. | $2.04 | 13.19M | — | — | — | — | -0.87 | 1.17 | — | -0.32 | — | 1.17 | 0.00% | — | — | -87.40% | -511.76% | -67.41% | 0.30 | — | 6.74 | 6.40 | -0.07 | -2658.00% | — | -2163.00% | -91.59% | -6.52 | -385.51% | 0.00% | 0.00% | 0.00% | -0.29 | -0.39 | — | -4.95 |
| TLPH | Talphera, Inc. | $0.91 | 18.7M | +3,728% | — | — | — | -1.09 | 1.78 | — | -0.78 | — | 1.78 | 0.00% | — | — | -117.65% | -293.62% | -67.32% | 0.82 | -38.71 | 3.56 | 3.35 | 0.15 | -6124.00% | -10000.00% | -2790.00% | -89.22% | -4.79 | -244.16% | 0.00% | 0.00% | 0.00% | -0.78 | -0.94 | — | -36.58 |
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.
- CEO
- Yen Feng Chhoa
- Employees
- 32
- Beta
- 0.04
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.56) − 1 = — (DCF, example).